Brivaracetam


( Last Updated : March 17, 2016)
Generic Name:
Brivaracetam
Project Status:
Complete
Therapeutic Area:
Epilepsy, partial-onset seizures
Manufacturer:
UCB Canada Inc.
Call for patient/clinician input open:
Brand Name:
Brivlera
Project Line:
Reimbursement Review
Project Number:
SR0484-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Epilepsy, partial-onset seizures
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: